UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Phase 1

Suspended

Conditions: Acute Biphenotypic Leukemia
Mixed Phenotype Acute Leukemia
Relapsed Acute Myeloid Leukemia
Relapsed Mixed Phenotype Acute Leukemia
Refractory Acute Myeloid Leukemia
Relapsed Acute Biphenotypic Leukemia
Relapsed Myeloid Neoplasm
Refractory Acute Biphenotypic Leukemia
Refractory Mixed Phenotype Acute Leukemia
Refractory Myeloid Neoplasm

Interventions: Drug: Cladribine
Drug: Cytarabine
Drug: Mitoxantrone
Biological: Recombinant Granulocyte Colony-Stimulating Factor
Drug: Venetoclax

First Posted Date: 2021-03-15

Last Posted Date: 2024-11-21

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT04797767

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza)

Conditions: Pneumonia, Viral

First Posted Date: 2021-03-08

Last Posted Date: 2021-03-12

Lead Sponsor: University of Washington

Target Recruit Count: 1200

Registration Number: NCT04786301

Locations: 🇺🇸
Bellevue Hospital Center, New York, New York, United States
🇺🇸
NYU Langone Medical Center, New York, New York, United States

Research Evaluating Sleep & Trends for Universal Prevention

Not Applicable

Completed

Conditions: Marijuana Use
Insomnia
Alcohol Use, Unspecified

Interventions: Behavioral: Brief Behavioral Therapy for Insomnia (BBTI)
Behavioral: Brief Alcohol Screening and Intervention for College Students (BASICS)

First Posted Date: 2021-03-05

Last Posted Date: 2024-06-07

Lead Sponsor: University of Washington

Target Recruit Count: 150

Registration Number: NCT04783519

Locations: 🇺🇸
The Center for the Study of Health and Risk Behaviors, Seattle, Washington, United States

An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer

Phase 2

Recruiting

Conditions: Castration-Resistant Prostate Carcinoma
Prostate Adenocarcinoma
Stage IV Prostate Cancer AJCC v8
Biochemically Recurrent Prostate Carcinoma

Interventions: Procedure: Computed Tomography
Drug: Gallium Ga 68 Gozetotide
Procedure: Positron Emission Tomography
Procedure: Magnetic Resonance Imaging
Procedure: Bone Scan

First Posted Date: 2021-03-02

Last Posted Date: 2024-11-20

Lead Sponsor: University of Washington

Target Recruit Count: 213

Registration Number: NCT04777071

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Assisted Partner Services and HIVST in Western Kenya

Not Applicable

Completed

Conditions: Hiv

Interventions: Diagnostic Test: Standard aPS
Diagnostic Test: HIVST

First Posted Date: 2021-03-01

Last Posted Date: 2022-10-19

Lead Sponsor: University of Washington

Target Recruit Count: 4941

Registration Number: NCT04774835

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Early Detection of GEnetic Risk (EDGE)

Not Applicable

Completed

Conditions: Genetic Predisposition

Interventions: Behavioral: Population-level screening

First Posted Date: 2021-02-10

Last Posted Date: 2024-10-09

Lead Sponsor: University of Washington

Target Recruit Count: 20184

Registration Number: NCT04746794

Locations: 🇺🇸
Billings Clinic, Billings, Montana, United States
🇺🇸
MultiCare Health System, Tacoma, Washington, United States

Research on Translational Outcomes of Alcohol (Project RETRO)

Phase 4

Withdrawn

Conditions: Alcohol Drinking

Interventions: Drug: Placebo
Drug: Carbidopa Levodopa

First Posted Date: 2021-02-08

Last Posted Date: 2023-02-13

Lead Sponsor: University of Washington

Registration Number: NCT04742348

Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease

Not Applicable

Completed

Conditions: Congenital Heart Disease

Interventions: Other: Usual Care
Behavioral: Promoting Resilience in Stress Management (PRISM)

First Posted Date: 2021-02-04

Last Posted Date: 2024-08-05

Lead Sponsor: University of Washington

Target Recruit Count: 78

Registration Number: NCT04738474

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Early Community Client-LED ART Delivery in Nakivale Refugee Settlement

Not Applicable

Completed

Conditions: HIV Seropositivity

Interventions: Behavioral: Early CCLAD

First Posted Date: 2021-02-03

Last Posted Date: 2023-07-11

Lead Sponsor: University of Washington

Target Recruit Count: 92

Registration Number: NCT04736316

Locations: 🇺🇬
Nakivale Refugee Settlement, Isingiro, Uganda

Enteral Resuscitation Nepal (Pilot Study)

Phase 3

Completed

Conditions: Burn Body Region Unspecified
Burn Shock

Interventions: Drug: Oral Rehydration Solution
Drug: Lactated Ringer

First Posted Date: 2021-02-01

Last Posted Date: 2023-10-11

Lead Sponsor: University of Washington

Target Recruit Count: 30

Registration Number: NCT04732624

Locations: 🇳🇵
Nepal Cleft and Burn Center at Kirtipur Hospital, Kirtipur, Bagmati, Nepal

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy